Skip to main content

Table 2 Clinical and ultrasound characteristics predicting malignancy of ACR TI-RADS 4 and 5 thyroid nodules

From: Dual-modal radiomics nomogram based on contrast-enhanced ultrasound to improve differential diagnostic accuracy and reduce unnecessary biopsy rate in ACR TI-RADS 4–5 thyroid nodules

Characteristic

Training (n = 219)

Validation (n = 93)

Benign (n = 66)

Malignant

(n = 153)

P value

Benign

(n = 27)

Malignant

(n = 66)

P value

Sex

0.468

  

0.032

Male

11 (16.7)

32 (20.9)

 

2 (7.4)

18 (27.3)

 

Female

55 (83.3)

121 (79.1)

 

25 (92.6)

48 (72.7)

 

Age (years)

0.029

  

0.620

Mean ± SD

42.83 ± 10.94

39.25 ± 11.11

 

40.85 ± 11.24

39.62 ± 10.64

 

Range

19–69

18–67

 

21–64

18–60

 

Tumor size (mm), median (IQR)

12 (8–20)

10 (8–15)

0.048

22 (17–29)

10 (6–15)

< 0.001

Primary site

0.033

  

0.589

Right

31 (47.0)

86 (56.2)

 

15 (55.6)

30 (45.5)

 

Left

35 (53.0)

61 (39.9)

 

11 (40.7)

31 (47.0)

 

Isthmus

0 (0)

6 (3.9)

 

1 (3.7)

5 (7.6)

 

Composition

0.032

  

0.029

Mixed cystic and solid

11 (16.7)

11 (7.2)

 

9 (33.3)

9 (13.6)

 

Solid or almost completely solid

55 (83.3)

142 (92.8)

 

18 (66.7)

57 (86.4)

 

Echogenicity

0.414

  

0.406

Hyperechoic or isoechoic

1 (1.5)

3 (2.0)

 

0 (0.0)

0 (0.0)

 

Hypoechoic

63 (95.5)

149 (97.4)

 

27 (100.0)

65 (98.5)

 

Very hypoechoic

2 (3.0)

1 (0.7)

 

0 (0.0)

1 (1.5)

 

Shape

< 0.001

  

0.014

Wider-than-tall

47 (71.2)

57 (37.3)

 

21 (77.8)

33 (50.0)

 

Taller-than wide

19 (28.8)

96 (62.7)

 

6 (22.2)

33 (50.0)

 

Margin

< 0.001

  

0.001

Smooth or ill-defined

27 (40.9)

12 (7.8)

 

8 (29.6)

2 (3.0)

 

Lobulated or irregular

39 (59.1)

138 (90.2)

 

19 (70.4)

61 (92.4)

 

Extra-thyroidal extension

0 (0)

3 (2)

 

0 (0.0)

3 (4.5)

 

Echogenic foci

< 0.001

  

0.298

None or large comet-tail artifacts

35 (53.0)

42 (27.5)

 

11 (40.7)

19 (28.8)

 

Macrocalcifications

8 (12.1)

12 (7.8)

 

2 (7.4)

2 (3.0)

 

Punctate echogenic foci

23 (34.8)

99 (64.7)

 

14 (51.9)

45 (68.2)

 

TI-RADS risk level

< 0.001

  

< 0.001

TR4

28 (42.4)

18 (11.8)

 

15 (55.6)

7 (10.6)

 

TR5

38 (57.6)

135 (88.2)

 

12 (44.4)

59 (89.4)

 

Enhancement direction

< 0.001

  

< 0.001

Scattered

31 (47.0)

26 (17.0)

 

15 (55.6)

11 (16.7)

 

Centripetal or centrifugal

35 (53.0)

127 (83.0)

 

12 (44.4)

55 (83.3)

 

Enhancement pattern

0.001

  

0.430

Homogeneous

22 (33.3)

22 (14.4)

 

5 (18.5)

8 (12.1)

 

Heterogeneous

44 (66.7)

131 (85.6)

 

22 (81.5)

58 (87.9)

 

Peak intensity

0.062

  

0.305

None- or iso-enhancement

18 (27.3)

25 (16.3)

 

7 (25.9)

11 (16.7)

 

Hypo- or Hyper-enhancement

48 (72.7)

128 (83.7)

 

20 (74.1)

55 (83.3)

 

Ring enhancement

< 0.001

  

< 0.001

Absent

47 (71.2)

145 (94.8)

 

15 (55.6)

60 (90.9)

 

Present

19 (28.8)

8 (5.2)

 

12 (44.4)

6 (9.1)

 

BMUS Rad-score, median (IQR)

0.64 (0.15–0.97)

1.05 (0.73–1.35)

< 0.001

0.49 (0.13–1.05)

0.95 (0.65–1.37)

0.001

CEUS Rad-score, median (IQR)

0.58 (0.03–1.06)

1.18 (0.85–1.40)

< 0.001

0.64 (0.07–0.70)

1.15 (0.87–1.40)

< 0.001

  1. Note: Data is the number of thyroid nodules with percentages in brackets unless otherwise noted. ACR TI-RADS = American College of Radiology Thyroid Imaging Reporting and Data System, SD = standard deviation, IQR = interquartile range, BMUS = B-mode ultrasound, CEUS = contrast-enhanced ultrasound